- Home
- DTST vs CRIS Comparison
DTST vs CRIS Comparison
Compare DTST & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTST | CRIS |
|---|---|---|
| Founded | 2001 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6M | 14.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | DTST | CRIS |
|---|---|---|
| Price | $5.00 | $1.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | ★ 129.2K | 110.0K |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8036.56 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $25,529,819.00 | $11,650,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | $2.66 | ★ N/A |
| Revenue Growth | ★ 260.19 | 13.56 |
| 52 Week Low | $2.93 | $1.02 |
| 52 Week High | $5.44 | $4.50 |
Technical Indicators
Market Signals| Indicator | DTST | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 76.90 | 40.13 |
| Support Level | $4.93 | $1.29 |
| Resistance Level | $5.05 | $1.41 |
| Average True Range (ATR) | 0.13 | 0.12 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 94.29 | 23.54 |
Price Performance
Historical ComparisonAbout DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.